ENGLEWOOD, CO, Nov 04, 2009 (MARKETWIRE via COMTEX) -- Biomedical Technology Solutions Holdings, Inc. ("BMTS" or the "Company"; www.bmtscorp.com) (OTCBB: BMTL) is pleased to announce the introduction of the Demolizer(R) II System into the Geisinger Health organization for the onsite treatment of biomedical waste.

The Geisinger Health System is one of the nation's leading fully integrated health services organizations. Founded in 1915, Geisinger is a physician-led health care system, dedicated to health care, education, research and service spanning 43 counties in Pennsylvania and serving over 2.6 million people in primarily rural communities.

The Demolizer(R) II is a safe and simple biomedical waste treatment system ideally suited to meet the unique needs of clinics in rural areas where the cost, both financial and environmental, of traditional transport and offsite disposal can be prohibitive. Cost savings from adoption of the Demolizer(R) II are expected to be significant. More importantly, the Demolizer(R) II is an environmentally responsible alternative treatment system approved by the Commonwealth of Pennsylvania that eliminates the need for onsite storage between pickups and substantially lowers the environmental impact associated with proper treatment and disposal of biomedical waste.

Geisinger Health has been repeatedly lauded for its best practices -- finding innovative solutions to provide high quality healthcare at costs well below average. Their success in these areas has been featured by President Obama in his address to the AMA, Time Magazine, U.S. News and World Report, CNN, the Philadelphia Inquirer and others.

Don Cox, President and CEO of BMTS, explains, "With Geisinger Health's longstanding reputation for value and quality, the decision to introduce the Demolizer II is a major milestone for our organization. This is another validation that our Demolizer(R) II System can deliver real cost savings and environmental benefits for the over one million biomedical waste generators in the U.S."

About Biomedical Technology Solutions Holdings, Inc.

Biomedical Technology Solutions Holdings, Inc., located in Englewood, Colorado sells the Demolizer(R) II through its wholly owned subsidiary Biomedical Technology Solutions, Inc. BMTS' patented Demolizer(R) Technology converts infectious biomedical waste into non-infectious material. BMTS' products provide biomedical waste treatment solutions for the over 1,000,000 low to medium volume medical waste generators in the US and a global market five times larger than the US. For more information, visit our investor relations page at www.bmtscorp.com.

About the Demolizer(R) II

The Demolizer(R) II is the GREEN alternative to biomedical waste disposal. The device is the only patented, portable, and self-contained system able to process both sharps and typical red bag biomedical waste onsite. The processed waste is rendered sterile and discarded as common trash eliminating up to 100% of the cost associated with its disposal. The Demolizer(R) II meets or exceeds all EPA and CDC guidelines and is approved or meets treatment requirements in 47 states after review by 78 governmental agencies. The device uses no chemicals or liquids, plugs into a normal outlet through a surge protector, and automatically records and prints state required documentation. The Demolizer(R) II provides a safer, more environmentally GREEN method for biomedical waste disposal.

Safe Harbor for Forward-Looking Statements

The statements contained in this press release may include certain projections and forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. Such statements involve a number of risks and uncertainties. Such statements reflect the Company's current views with respect to future events and financial performance. No assurances can be given however, that these events will occur or that such expectations will be achieved and that actual results could differ materially from those described. Actual results of future operations of Biomedical Technology Solutions Holdings, Inc. may differ materially from those indicated by these forward-looking statements as a result of various important factors.

Contact: David Kempf COO/CFO 303 653-0100

SOURCE: Biomedical Technology Solutions Holdings